2025年的肌痛性骨髓炎:五个新事物和未来的四个希望
S N M Binks1,2, I M Morse3, Mohammad Ashraghi1
1Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK.
Journal of neurology
|February 22, 2025
概括
最近的进展为肌痛性脑膜炎 (MG) 患者提供了新的希望,引入了新的疗法,如B细胞枯竭和补充抑制. 该审查强调了改进的治疗算法和持续缓解和神经肌肉保护的未来方向.
科学领域:
- 神经学 神经学
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 骨髓灰质炎 (MG) 是一种慢性自身免疫神经肌肉疾病.
- 近年来,在MG治疗方面取得了重大突破.
- 现有的治疗方法提供症状缓解,但往往无法持续缓解.
研究的目的:
- 提供关于近期肌痛性骨髓灰质炎治疗的最新进展的最新评论.
- 检查新疗法在当前治疗算法中的作用.
- 解决包括生物标志物,老年患者和未来治疗方向在内的关键问题.
主要方法:
- 临床试验和监管批准的文献审查.
- 对临床免疫学数据的分析.
- 讨论新出现的生物标志物和治疗策略.
主要成果:
- 现在可以使用新的治疗方法,包括B细胞枯竭,补充抑制和FcRn阻塞.
- 这些疗法为持续缓解和神经肌肉保护提供了更好的前景.
- 专注于用于老年患者预后和管理的生物标志物,包括晚发性MG (LOMG).
结论:
- 在过去的十年里,用新型免疫调节疗法改变了MG治疗.
- 未来的研究应该集中在快速诊断,神经肌肉保护和了解老年人的治疗反应上.
- 像CAR-T细胞这样的新兴疗法对持久反应有希望.
相关概念视频
Myasthenia Gravis: Overview and Treatment
1.1K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.1K
Myasthenia Gravis: Diagnostic Tests
601
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
601
Disorders of the Skeletal Muscle
855
The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
855
Skeletal Muscle Relaxants: Therapeutic Uses
460
Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx...
460
Chemical Synapses
8.6K
Chemical synapses are specialized sites between two neurons or between a neuron and a non-neuronal cell like a muscle, glandular or sensory cell.
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
8.6K
Direct-Acting Cholinergic Agonists: Therapeutic Uses
667
Direct-acting cholinergic agonists have many therapeutic uses in various medical fields. Choline esters, including acetylcholine, have limited clinical utility due to their non-selectivity and short duration of action. Still, acetylcholine and carbachol are applied topically during ophthalmologic surgery to induce miosis. Pilocarpine, a muscarinic and ganglionic stimulator, effectively treats open-angle glaucoma and alleviates xerostomia and dry mouth caused by radiotherapy or Sjögren...
667


